text_1: Inhibiting HDAC6 increases survival of mice with ARID1A mutated tumors.
text_2: ARID1A, encoding a subunit of the SWI/SNF chromatin-remodelling complex, is the most frequently mutated epigenetic regulator across all human cancers.